Article
The success of SARS-CoV-2 vaccines and challenges ahead.
Cell host & microbe - 14 Jul 2021
Subbarao Kanta
Abstract excerpt
The rapid and remarkably successful development, manufacture, and deployment of several effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is now tempered by three key challenges. First, reducing virus transmission will require prevention of asymptomatic and mild infections in addition to severe symptomatic infections. Second, the emergence of variants of concern with mutations in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
